Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Net Margin (2017 - 2025)

Nutex Health's Net Margin history spans 14 years, with the latest figure at 10.95% for Q4 2025.

  • For Q4 2025, Net Margin fell 2767.0% year-over-year to 10.95%; the TTM value through Dec 2025 reached 17.26%, down 253.0%, while the annual FY2025 figure was 20.61%, 973.0% up from the prior year.
  • Net Margin for Q4 2025 was 10.95% at Nutex Health, down from 38.6% in the prior quarter.
  • Across five years, Net Margin topped out at 476.56% in Q1 2022 and bottomed at 1488.0% in Q3 2022.
  • The 5-year median for Net Margin is 5.29% (2024), against an average of 54.68%.
  • The largest annual shift saw Net Margin crashed -153360bps in 2022 before it skyrocketed 148079bps in 2023.
  • A 5-year view of Net Margin shows it stood at 40.44% in 2021, then crashed by -54bps to 18.48% in 2022, then tumbled by -315bps to 39.78% in 2023, then soared by 197bps to 38.62% in 2024, then plummeted by -72bps to 10.95% in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Net Margin are 10.95% (Q4 2025), 38.6% (Q3 2025), and 6.62% (Q2 2025).